CABALETTA BIO INC's ticker is CABA and the CUSIP is 12674W109. A total of 62 filers reported holding CABALETTA BIO INC in Q1 2022. The put-call ratio across all filers is 0.03 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $17,698,106 | -54.4% | 2,366,057 | +3.9% | 0.00% | -100.0% |
Q1 2024 | $38,832,347 | -19.8% | 2,276,222 | +6.8% | 0.00% | 0.0% |
Q4 2023 | $48,394,834 | +61.6% | 2,131,931 | +8.3% | 0.00% | 0.0% |
Q3 2023 | $29,954,604 | +34.8% | 1,968,108 | +14.3% | 0.00% | 0.0% |
Q2 2023 | $22,224,721 | +141.3% | 1,721,512 | +54.5% | 0.00% | – |
Q1 2023 | $9,212,308 | +7.2% | 1,113,943 | +19.9% | 0.00% | – |
Q4 2022 | $8,594,998 | +934.3% | 929,189 | -27.3% | 0.00% | – |
Q3 2022 | $831,000 | -25.5% | 1,278,551 | +21.6% | 0.00% | – |
Q2 2022 | $1,115,000 | -47.8% | 1,051,838 | 0.0% | 0.00% | – |
Q1 2022 | $2,135,000 | -37.7% | 1,051,838 | +16.3% | 0.00% | – |
Q4 2021 | $3,428,000 | -61.4% | 904,492 | +23.8% | 0.00% | – |
Q3 2021 | $8,887,000 | +41.5% | 730,781 | +0.1% | 0.00% | – |
Q2 2021 | $6,280,000 | -18.5% | 730,199 | +5.2% | 0.00% | – |
Q1 2021 | $7,701,000 | -5.8% | 693,885 | +6.0% | 0.00% | – |
Q4 2020 | $8,173,000 | +31.5% | 654,903 | +14.2% | 0.00% | – |
Q3 2020 | $6,215,000 | +116.9% | 573,330 | +122.8% | 0.00% | – |
Q2 2020 | $2,866,000 | +29.0% | 257,277 | -15.5% | 0.00% | – |
Q1 2020 | $2,222,000 | -47.7% | 304,393 | +0.1% | 0.00% | – |
Q4 2019 | $4,247,000 | – | 303,990 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Lynx1 Capital Management LP | 2,825,976 | $26,140,278 | 22.61% |
VR Adviser, LLC | 1,895,285 | $17,531,386 | 2.95% |
CAXTON CORP | 84,728 | $783,735 | 2.00% |
COMMODORE CAPITAL LP | 1,010,359 | $9,346 | 1.41% |
BOONE CAPITAL MANAGEMENT LLC | 266,882 | $2,468,659 | 1.27% |
Cormorant Asset Management, LP | 1,971,739 | $18,239 | 1.22% |
TCG Crossover Management, LLC | 486,795 | $4,502,854 | 0.80% |
Boxer Capital, LLC | 540,000 | $4,995,000 | 0.26% |
Kynam Capital Management, LP | 165,486 | $1,530,746 | 0.24% |
Eversept Partners, LP | 282,874 | $2,616,585 | 0.23% |